| Medical and Health Sciences | Lifetime | 121 | CA 5 | 99.99 |
| Medical and Health Sciences | 2021-2025 | 150 | CA 7 | 99.97 |
| Psychology and Behavioral Sciences | 2021-2025 | 490 | CA 28 | 98.77 |
| Epidemiology | Lifetime | 21 | CA 1 | 99.97 |
| Pathology and Forensic Medicine | Lifetime | 11 | CA 3 | 99.95 |
| General Health Professions | Lifetime | 121 | CA 15 | 99.84 |
| Public, Environmental and Occupational Health | Lifetime | 95 | CA 6 | 99.85 |
| Clinical Pharmacology | Lifetime | 159 | CA 11 | 99.36 |
| Pediatrics, Perinatology and Child Health | Lifetime | 380 | CA 33 | 98.89 |
| Health | Lifetime | 191 | CA 8 | 98.85 |
| Clinical Psychology | Lifetime | 696 | CA 42 | 99.04 |
| Organizational Behavior and Human Resource Management | Lifetime | 699 | CA 48 | 97.91 |
| Safety, Risk, Reliability and Quality | Lifetime | 758 | CA 36 | 93.96 |
| Epidemiology | 2021-2025 | 27 | CA 1 | 99.88 |
| Pathology and Forensic Medicine | 2021-2025 | 6 | CA 1 | 99.78 |
| General Health Professions | 2021-2025 | 73 | CA 6 | 99.51 |
| Public, Environmental and Occupational Health | 2021-2025 | 152 | CA 10 | 98.69 |
| Clinical Psychology | 2021-2025 | 220 | CA 17 | 98.42 |
| Health | 2021-2025 | 87 | CA 3 | 97.92 |
| Clinical Pharmacology | 2021-2025 | 113 | CA 10 | 96.24 |
| Organizational Behavior and Human Resource Management | 2021-2025 | 201 | CA 10 | 95.57 |
| Alcohol Consumption and Health Effects | Lifetime | 1 | CA 1 | 99.90 |
| Substance Abuse Treatment and Outcomes | Lifetime | 1 | CA 1 | 99.95 |
| Homelessness and Social Issues | Lifetime | 3 | CA 1 | 99.94 |
| Alcoholism and Thiamine Deficiency | Lifetime | 2 | CA 1 | 99.54 |
| Prenatal Substance Exposure Effects | Lifetime | 5 | CA 1 | 99.68 |
| Opioid Use Disorder Treatment | Lifetime | 7 | CA 3 | 99.77 |
| Cannabis and Cannabinoid Research | Lifetime | 21 | CA 2 | 99.63 |
| Liver Disease Diagnosis and Treatment | Lifetime | 167 | CA 3 | 99.73 |
| HIV, Drug Use, Sexual Risk | Lifetime | 60 | CA 6 | 99.53 |
| Health disparities and outcomes | Lifetime | 102 | CA 4 | 99.42 |
| Global Public Health Policies and Epidemiology | Lifetime | 55 | CA 5 | 99.03 |
| Health Promotion and Cardiovascular Prevention | Lifetime | 29 | CA 1 | 99.17 |
| Diabetes, Cardiovascular Risks, and Lipoproteins | Lifetime | 242 | CA 13 | 99.10 |
| Mental Health Treatment and Access | Lifetime | 185 | CA 8 | 99.00 |
| Nutritional Studies and Diet | Lifetime | 345 | CA 12 | 98.75 |
| Smoking Behavior and Cessation | Lifetime | 174 | CA 7 | 98.14 |
| Gestational Diabetes Research and Management | Lifetime | 316 | CA 25 | 98.01 |
| COVID-19 and Mental Health | Lifetime | 575 | CA 29 | 96.08 |
| Food Security and Health in Diverse Populations | Lifetime | 415 | CA 23 | 96.74 |
| Pain Management and Opioid Use | Lifetime | 257 | CA 19 | 97.30 |
| Eicosanoids and Hypertension Pharmacology | Lifetime | 597 | CA 23 | 96.62 |
| Forensic Toxicology and Drug Analysis | Lifetime | 250 | CA 10 | 96.33 |
| Global Health Care Issues | Lifetime | 686 | CA 24 | 95.50 |
| Gambling Behavior and Treatments | Lifetime | 135 | CA 22 | 95.22 |
| Employment and Welfare Studies | Lifetime | 786 | CA 46 | 95.38 |
| Health and Medical Studies | Lifetime | 438 | CA 1 | 94.38 |
| Poisoning and overdose treatments | Lifetime | 379 | CA 20 | 94.28 |
| Bipolar Disorder and Treatment | Lifetime | 952 | CA 60 | 95.28 |
| Health Policy Implementation Science | Lifetime | 760 | CA 88 | 94.40 |
| Suicide and Self-Harm Studies | Lifetime | 907 | CA 51 | 93.97 |
| Psychiatric care and mental health services | Lifetime | 805 | CA 29 | 90.75 |
| Wine Industry and Tourism | Lifetime | 646 | CA 20 | 89.76 |
| Psychedelics and Drug Studies | Lifetime | 859 | CA 25 | 81.73 |
| Survey Methodology and Nonresponse | Lifetime | 698 | CA 19 | 61.00 |
| Homelessness and Social Issues | 2021-2025 | 1 | CA 1 | 99.87 |
| Substance Abuse Treatment and Outcomes | 2021-2025 | 1 | CA 1 | 99.92 |
| Alcohol Consumption and Health Effects | 2021-2025 | 3 | CA 1 | 99.65 |
| Health disparities and outcomes | 2021-2025 | 87 | CA 2 | 97.93 |
| Liver Disease Diagnosis and Treatment | 2021-2025 | 428 | CA 11 | 97.92 |
| COVID-19 and Mental Health | 2021-2025 | 362 | CA 22 | 96.55 |
| HIV, Drug Use, Sexual Risk | 2021-2025 | 108 | CA 18 | 97.53 |
| Opioid Use Disorder Treatment | 2021-2025 | 81 | CA 14 | 97.66 |
| Cannabis and Cannabinoid Research | 2021-2025 | 85 | CA 17 | 96.44 |
| Global Public Health Policies and Epidemiology | 2021-2025 | 106 | CA 4 | 93.59 |
| Food Security and Health in Diverse Populations | 2021-2025 | 175 | CA 16 | 94.83 |
| Prenatal Substance Exposure Effects | 2021-2025 | 72 | CA 11 | 94.63 |
| Suicide and Self-Harm Studies | 2021-2025 | 188 | CA 8 | 95.13 |
| Mental Health Treatment and Access | 2021-2025 | 310 | CA 18 | 93.39 |
| Employment and Welfare Studies | 2021-2025 | 236 | CA 23 | 91.49 |
| Healthcare Policy and Management | 2021-2025 | 427 | CA 24 | 89.08 |
| Diabetes, Cardiovascular Risks, and Lipoproteins | 2021-2025 | 685 | CA 21 | 87.50 |
| Health Policy Implementation Science | 2021-2025 | 587 | CA 75 | 86.49 |
| Smoking Behavior and Cessation | 2021-2025 | 467 | CA 21 | 88.58 |
| Health Promotion and Cardiovascular Prevention | 2021-2025 | 115 | CA 6 | 82.01 |
| Poisoning and overdose treatments | 2021-2025 | 256 | CA 14 | 77.41 |
| Alcoholism and Thiamine Deficiency | 2021-2025 | 172 | CA 7 | 68.71 |
| Forensic Toxicology and Drug Analysis | 2021-2025 | 734 | CA 41 | 69.54 |
| demographic modeling and climate adaptation | 2021-2025 | 213 | CA 8 | 41.84 |
